| Literature DB >> 1222217 |
J L Imbach, J L Montero, A Moruzzi, B Serrou, E Chenu, M Hayat, G Mathe.
Abstract
Four new nitrosourea derivatives represent an appreciable progress in the treatment and cure of L1210 leukemia. Their therapeutic index is higher than that of CCNU and MeCCNU. Of these compounds, RFCNU may prove the most promising, as its therapeutic index is the highest of those for all the four compounds studied; moreover, unlike the other products, it is not immunosuppressive, whether administered before or after the antigen.Entities:
Mesh：
Substances：
Year: 1975 PMID： 1222217
Source DB: PubMed Journal: Biomedicine ISSN： 0300-0893